Pediatric Heart Transplantation: Transitioning to Adult Care
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Heart Transplantation
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Enrollment
- 88
- Locations
- 6
- Primary Endpoint
- To assess the feasibility of TRANSIT by measuring the transition program adherence for those randomized to the intervention and survey completion for all participants.
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The purpose of this pilot trial, Transitioning to Adult Care (TRANSIT), is to develop and test an intervention (i.e., a standardized, tailored transition program focused on enhancing adherence) to improve outcomes for emerging adults who underwent heart transplantation as children and transfer to adult care.
Investigators
Elfriede Pahl, MD
Attending Physician, Division of Cardiology
Ann & Robert H Lurie Children's Hospital of Chicago
Eligibility Criteria
Inclusion Criteria
- •Have received a heart transplant at a children's hospital and are ready to transition, as determined by the pediatric heart transplant cardiologist, to the adult heart transplant center with whom a collaborative relationship has been established;
- •18 years or older;
- •Able to speak, read at a fifth grade level or above, and write English;
- •Physically able to participate.
Exclusion Criteria
- •History of psychiatric hospitalization within the last 3 months, assessed on a case-by-case basis with exclusion only if patients could not potentially benefit from the intervention.
Outcomes
Primary Outcomes
To assess the feasibility of TRANSIT by measuring the transition program adherence for those randomized to the intervention and survey completion for all participants.
Time Frame: 6 months
Investigators hypothesize that by the end of the 3 month transition program and 6 months of follow-up, 84% of patients will be retained; 80% will participate in the program (module completion, discussion, and follow-up); and 100% will complete at least 80% of the survey instruments at each data collection point.
Secondary Outcomes
- To determine the efficacy of TRANSIT on patient-level outcomes .(6 months)
- To determine the efficacy of TRANSIT on meso-level outcomes.(6 Months)